For: | Kosmas CE, Sourlas A, Silverio D, Montan PD, Guzman E. Novel lipid-modifying therapies addressing unmet needs in cardiovascular disease. World J Cardiol 2019; 11(11): 256-265 [PMID: 31798792 DOI: 10.4330/wjc.v11.i11.256] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v11/i11/256.htm |
Number | Citing Articles |
1 |
Linqi Zhang, Xiao Wang, Xiao-Wei Chen. The biogenesis and transport of triglyceride-rich lipoproteins. Trends in Endocrinology & Metabolism 2024; doi: 10.1016/j.tem.2024.07.015
|
2 |
Hae Won Lee, Woo Youl Kang, Wookjae Jung, Mi-Ri Gwon, Kyunghee Cho, Dong Heon Yang, Young-Ran Yoon, Sook Jin Seong. Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers. Pharmaceutics 2020; 12(9): 869 doi: 10.3390/pharmaceutics12090869
|
3 |
Raman Goit, Samia E Saddik, Sarah N Dawood, Ahmad M Rabih, Ahmad Niaj, Aishwarya Raman, Manish Uprety, Maria Jose Calero, Maria Resah B Villanueva, Narges Joshaghani, Nicole Villa, Omar Badla, Safeera Khan. Bempedoic Acid’s Use as an Adjunct in Lowering Low-Density Lipoprotein Cholesterol in Patients With Coronary Artery Disease: A Systematic Review. Cureus 2022; doi: 10.7759/cureus.29891
|
4 |
Ivan Pećin, Željko Reiner. Novel Experimental Agents for the Treatment of Hypercholesterolemia. Journal of Experimental Pharmacology 2021; : 91 doi: 10.2147/JEP.S267376
|